Not independent
Tenure on this board
1.9 yrs
Also a director at
Edwards Lifesciences Corp (EW)
Meeting calendar
PLSE · Special meeting · Tuesday, September 30, 2025
Pulse Biosciences Inc
4 nominees · 3 ballot items.
Pulse Biosciences, Inc. Special Meeting proposals: Proposal 1 to amend the 2017 Equity Incentive Plan by increasing authorized shares and redefining 'Consultant'; Proposal 2 to ratify the grant of options under the Equity Plan (subject to Proposal 1); Proposal 3 to transact any other business as may properly come before the Special Meeting.
Market cap
$2.0B
1Y TSR
+60.2%
Board grade
B-
Record date
Aug 25, 2025
Filing
DEF 14A
Meeting concluded · Sep 30, 2025
Follow how the vote landed and what changed on Pulse Biosciences Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
Proposals
On the ballot3
- 1
AMENDMENT TO THE PULSE BIOSCIENCES, INC. 2017 EQUITY INCENTIVE PLAN TO INCREASE THE NUMBER OF SHARES OF COMMON STOCK AND TO CHANGE THE DEFINITION OF “CONSULTANT”
ManagementBoard: FORIncrease authorized shares by 2,000,000 and modify the definition of 'Consultant' to permit awards through an employer of record.
- 2
RATIFICATION OF THE GRANT OF OPTIONS TO ACQUIRE COMMON STOCK GRANTED TO AN EXECUTIVE AND CERTAIN DIRECTORS AND CONSULTANTS OF THE COMPANY PURSUANT TO THE EQUITY PLAN
ManagementBoard: FORRatify stock option awards granted on August 9, 2024 and January 21, 2025 under the Equity Plan, subject to Proposal 1.
- 3
PROPOSAL 3: TRANSACT ANY OTHER BUSINESS AS MAY PROPERLY COME BEFORE THE SPECIAL MEETING OR ANY ADJOURNMENTS OR POSTPONEMENTS THEREOF
ManagementTo transact any other business as may properly come before the Special Meeting or any adjournments or postponements thereof.
Director elections
Nominees on the ballot4
Not independent
Tenure on this board
8.7 yrs
Also a director at
Summit Therapeutics Inc (SMMT)
Not independent
Tenure on this board
9.4 yrs
Also a director at
Summit Therapeutics Inc (SMMT)
Independent
Tenure on this board
New nominee
Ownership
Latest 13F quarterTop institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BANK OF AMERICA CORP /DE/ | 1.3% | 866,061 | $19M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2% | 815,852 | $18M |
| 3 | Portolan Capital Management, LLC | 1.1% | 733,372 | $16M |
| 4 | BlackRock, Inc. | 1.0% | 683,017 | $15M |
| 5 | BlackRock, Inc. | 0.7% | 493,117 | $11M |
| 6 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0.7% | 462,899 | $10M |
| 7 | STATE STREET CORP | 0.7% | 456,927 | $10M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 0.6% | 428,167 | $9M |
| 9 | BALYASNY ASSET MANAGEMENT L.P. | 0.4% | 265,164 | $6M |
| 10 | GRIFFIN ASSET MANAGEMENT, INC. | 0.3% | 225,177 | $5M |
Peers
Nearest market capOther Healthcare sector meetings6
Upcoming shareholder meetings at Pulse Biosciences Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Anaptysbio IncANAB
Annual meeting·Aug 11, 2026·$2.0B
Trulieve Cannabis CorpTRLV
Special meeting·Aug 5, 2026·$1.9B
Prestige Consumer Healthcare IncPBH
Annual meeting·Aug 4, 2026·$2.2B
Avanos Medical IncAVNS
Special meeting·Jul 22, 2026·$1.2B
Esperion Therapeutics IncESPR
Special meeting·Jul 8, 2026·$814M
Aura Biosciences IncAURA
Special meeting·Aug 5, 2026·$734M
Reference
Frequently asked questions
- When is the Pulse Biosciences Inc 2025 special meeting?
- Pulse Biosciences Inc (PLSE) holds its 2025 special shareholder meeting on Tuesday, September 30, 2025.
- What is the record date for the Pulse Biosciences Inc 2025 meeting?
- The record date for the Pulse Biosciences Inc 2025 meeting is Monday, August 25, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Pulse Biosciences Inc's 2025 meeting?
- The board is presenting 4 director nominees at the Pulse Biosciences Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Pulse Biosciences Inc 2025 meeting?
- Shareholders will vote on 3 proposals at the Pulse Biosciences Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
Disclaimer
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.